Solid Biosciences Inc. Common Stock (SLDB) is a publicly traded Healthcare sector company. As of November 4, 2026, SLDB trades at $6.64 with a market cap of $673.37M and a P/E ratio of -3.60. SLDB moved +3.82% today. Year to date, SLDB is +22.29%; over the trailing twelve months it is +47.97%. Its 52-week range spans $2.41 to $11.45. Analyst consensus is strong buy with an average price target of $20.00. Rallies surfaces SLDB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for SLDB, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $6.64 |
| Market Cap | $673.37M |
| P/E Ratio | -3.60 |
| EPS | $-1.99 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.45 |
| 52-Week Low | $2.41 |
| Volume | 920.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-174.32M |
| Gross Margin | 0.00% |
11 analysts cover SLDB: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.00.